株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の動物医療・診断市場

Global Markets for Animal Therapeutics and Diagnostics

発行 BCC Research 商品コード 242225
出版日 ページ情報 英文 256 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
世界の動物医療・診断市場 Global Markets for Animal Therapeutics and Diagnostics
出版日: 2017年02月13日 ページ情報: 英文 256 Pages
担当者のコメント
世界の動物医療、飼料添加物、診断用製品市場を分析しており、また家畜とペットも含んでいる包括的なレポートです
概要

世界における動物の医療および診断市場は、2016年から2021年にかけて3.6%のCAGR (年間複合成長率) を示し、2016年の約401億米ドルから2021年の479億米ドルへ達すると予測されています。

当レポートでは、世界の動物医療・診断市場の現状と見通しについて調査分析し、世界市場の概要、市場動向の分析とCAGR予測、市販製品の詳細、競合環境の分析、市場ダイナミクスの分析、および主要企業のプロファイルなどを提供しています

第1章 イントロダクション

第2章 サマリー

第3章 産業概要

  • 動物解剖学・生理学
    • 生殖システム
    • 鳥類解剖学
  • 動物個体数:米国
    • コンパニオンアニマル
    • 家畜
    • 動物個体数:国別
  • コンパニオンアニマルの疾患
  • 人畜共通感染症

第4章 市場影響因子

  • 概要
  • 法規制上の課題
  • アニマルヘルスにおけるバイオテクノロジー
  • 動物の肥満
  • コンパニオンペットの飼育動向
  • 動物の医療保険
  • 高度医療処置
  • ライフサイクルアプローチ
  • 獣医サービス産業における需要

第5章 動物用ワクチン

  • 概要
  • 世界市場の分析・検討事項
  • 世界市場:地域別
  • 競合サマリー
  • 製品概要
    • 能動免疫
    • 受動免疫
    • その他の種類
  • コンパニオンアニマル
    • ウィルス
    • ワクチンプロバイダー
    • コンパニオンアニマル用ワクチン市場の分析
  • 家畜
    • ウィルス・プリオン
    • ワクチンプロバイダー
    • 家畜用ワクチン市場の分析

第6章 動物用医薬品

  • 概要
  • 世界市場の分析・検討事項
  • コンパニオンアニマル vs. 家畜市場
  • 市場:地域別
  • 競合サマリー
  • 製品概要
    • アレルギー・呼吸器疾患用医薬品
    • 抗感染薬・抗真菌薬
    • 抗炎症薬・鎮痛薬
    • 代謝・内分泌疾患用医薬品
    • 寄生虫駆除剤
    • 向精神薬

第7章 動物用飼料添加物

  • 概要
  • 世界市場の分析・検討事項
  • コンパニオンアニマル vs. 家畜市場
  • 市場:地域別
  • 競合サマリー
  • 製品概要
    • アミノ酸
  • 医薬品添加物
    • プロバイダー
    • 栄養補給剤
    • ビタミン・ミネラル

第8章 動物用診断製品

  • 概要
  • 世界市場の分析・検討事項
  • コンパニオンアニマル vs. 家畜市場
  • 市場:地域別
  • 競合サマリー
  • 製品プロバイダーと説明
    • ABAXIS
    • BEAPHAR
    • HESKA
    • IDEXX
    • MERCK ANIMAL HEALTH
    • VIRBAC
    • ZOETIS
  • 市場区分
    • 診断用迅速検査市場の分析
    • 診断用アナライザー・消耗品市場の分析
    • 診断用画像装置市場の分析

第9章 市場サマリー

  • 動物医療・診断市場:総市場の分析
  • 市場:用途または動物グループ別
  • 市場:地域別
  • 競合分析

第10章 特許分析

  • 概要
  • ドラッグデリバリーにおけるイノベーション
    • 経皮薬 (スプレー式)
    • 舌下薬
    • 発泡錠ワクチンデリバリー
    • 滅菌法
  • 特許製品区分

第11章 企業プロファイル

  • 概要
  • プロファイル
    • ABAXIS INC.
    • AJINOMOTO CO. INC.
    • ARATANA THERAPEUTICS INC.
    • BASF ANIMAL NUTRITION
    • BAYER ANIMAL HEALTH GMBH
    • BLUESTAR GROUP-CHINA NATIONAL BLUESTAR CO. LTD.
    • BOEHRINGER INGELHEIM VETMEDICA INC.
    • DSM NUTRITIONAL PRODUCTS LTD.
    • ELANCO ANIMAL HEALTH
    • EVONIK INDUSTRIES AG
    • HESKA CORP.
    • IDEXX LABORATORIES INC.
    • MERCK ANIMAL HEALTH
    • MERIAL SAS
    • MOSAIC CO. (THE)
    • VIRBAC S.A.
    • ZOETIS INC.

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC034E

Report Highlights

The global market for animal therapeutics and diagnostics totaled nearly $40.1 billion in 2016 and should total $47.9 billion in 2021, registering a compound annual growth rate (CAGR) of 3.6% for the period 2016-2021.

Report Includes

  • An overview of the global markets for animal therapeutics and diagnostics
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Details about products currently in the market
  • Analysis of the competitive environment
  • A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
  • Profiles of major players in the industry

Report Scope

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

Analyst Credentials

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices and emerging healthcare technologies. Ms. Elder has more than 20 years of experience in the healthcare industry, specializing in market research for the past 16 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into a wide range of healthcare markets.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • INFORMATION SOURCES
  • RELATED BCC RESEARCH REPORTS
  • ANALYST'S CREDENTIALS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • MARKET OVERVIEW
  • SUMMARY TABLE: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
    • LEADING MANUFACTURERS AND SUPPLIERS

CHAPTER 3 - INDUSTRY OVERVIEW

  • ANIMAL ANATOMY AND PHYSIOLOGY
    • REPRODUCTIVE SYSTEM
      • TABLE 1: GESTATION PERIODS OF SELECT COMMON SPECIES
    • AVIAN ANATOMY
      • TABLE 2: LIFESPAN OF COMMON AVIAN SPECIES OF PETS
  • ANIMAL POPULATIONS IN THE UNITED STATES
    • COMPANION ANIMALS
      • TABLE 3: STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016 (THOUSANDS/%)
      • TABLE 4: ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016 (THOUSANDS)
    • FOOD PRODUCTION ANIMALS
      • TABLE 5: REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017 (THOUSANDS)
      • Livestock Production - Top States
        • TABLE 6: TOP BROILER PRODUCING STATES, 2015 (THOUSANDS)
        • TABLE 7: TOP RED MEAT PRODUCING STATES, 1990 AND 2015 (%)
    • ANIMAL POPULATIONS BY COUNTRY
      • DOGS
        • TABLE 8: DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
      • CATS
        • TABLE 9: CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
      • HORSES
        • TABLE 10: HORSE (EQUINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
      • CATTLE
        • TABLE 11: CATTLE (BOVINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
      • SWINE
        • TABLE 12: PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
      • SHEEP
      • GOATS
    • ZOONOTIC DISEASES
      • TABLE 13: COMMON EXAMPLES OF ZOONOTIC DISEASES

CHAPTER 4 - ISSUES AFFECTING THE MARKET

  • OVERVIEW
  • LEGAL AND REGULATORY ISSUES
    • REGULATORY AGENCIES INVOLVED IN ANIMAL HEALTH AND WELFARE
      • Food and Drug Administration (FDA)
      • FDA's Center for Veterinary Medicine (CVM)
      • U.S. Department of Agriculture (USDA)
      • European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP)
      • Australian Pesticides and Veterinary Medicines Authority (APVMA)
      • The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil
    • ANTIBIOTIC USE AND RESISTANCE IN PRODUCTION ANIMALS
      • FDA's Antimicrobial Restrictions
        • TABLE 14: AFFECTED PIONEER ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES
      • Losing Livestock
      • Corporate Response Concerning Responsible Use
      • Therapeutic Use
      • Resistance
        • TABLE 15: ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014 (KG*)
      • Human Side Effects
      • Microbial Ecology
      • Agriculture and Food Research Initiative
      • Levels of Contaminated Meats in the U.S.
      • Movement for Lower Amounts of Antibiotics in Livestock Production
    • MINIMALLY AND HIGHLY REGULATED PRODUCTS
    • ANIMAL DRUG USER FEE ACT OF 2003
    • ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA II)
    • ANIMAL DRUG USER FEE AMENDMENTS OF 2013 (ADUFA III)
  • BIOTECHNOLOGY IN ANIMAL HEALTH
    • ANIMAL CLONING
    • PROBIOTICS
  • ANIMAL OBESITY
    • CAUSES
    • WEIGHT REDUCTION
  • TRENDS IN COMPANION PET OWNERSHIP
  • ANIMAL HEALTH INSURANCE
    • TABLE 16: APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS (U.S. SPENDING, $)
    • TABLE 17: PET INSURANCE PLAN COMPARISONS, UNITED STATES
  • ADVANCED MEDICAL PROCEDURES
  • LIFE CYCLE APPROACH
  • DEMAND IN THE VETERINARY SERVICE INDUSTRY
    • TABLE 18: NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015
    • FIGURE 1: NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS 2015
    • TABLE 19: ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015
    • TABLE 20: GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • FIGURE 2: ESTIMATED NUMBER OF VETERINARIANS IN THE UNITED STATES BY GENDER* AND YEAR, 2009-2015

CHAPTER 5 - ANIMAL VACCINES

  • OVERVIEW
  • GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
    • TABLE 21: GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • FIGURE 3: GLOBAL MARKET SHARES OF ANIMAL VACCINES BY ANIMAL GROUP, 2016 (%)
  • GLOBAL MARKET BY GEOGRAPHICAL REGION
    • TABLE 22: GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 4: GLOBAL MARKET SHARES OF ANIMAL VACCINES BY REGION, 2016 (%)
  • COMPETITIVE SUMMARY
    • TABLE 23: GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
    • FIGURE 5: GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
  • PRODUCT INTRODUCTION
    • ACTIVE IMMUNITY
    • PASSIVE IMMUNITY
    • OTHER TYPES
  • COMPANION ANIMALS
    • VIRUSES
      • Adenovirus
      • Avian Influenza
      • Coronavirus
      • Distemper
      • Eastern Equine Encephalitis
      • Equine Viral Arteritis
      • Feline Calicivirus and Feline Herpes Virus
      • Feline Immunosuppressive Virus
      • Feline Infectious Peritonitis Virus
      • Feline Leukemia Virus
      • Hendra Virus
        • TABLE 24: HENDRA VIRUS EQUINE INCIDENTS (NUMBER OF REPORTED CASES)
      • Infectious Hepatitis
      • Internal Papillomatosis of Parrots
      • Newcastle Disease
      • Pacheco's Disease
      • Parainfluenza Virus
      • Paramyxoviruses
      • Parvovirus
      • Polyomavirus
      • Poxviruses
      • Psittacine Beak and Feather Disease
      • Rabies
      • Reovirus
      • West Nile Virus
    • VACCINE PROVIDERS
      • Boehringer Ingelheim/Vetmedica
        • TABLE 25: BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 6: BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Elanco
        • TABLE 26: ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
      • Merck Animal Health
        • TABLE 27: MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 7: MERCK'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Merial
        • TABLE 28: MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 8: MERIAL'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Zoetis
        • TABLE 29: ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 9: ZOETIS' COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • COMPANION ANIMAL VACCINES MARKET ANALYSIS
      • FIGURE 10: GLOBAL MARKET FOR COMPANION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021 ($ MILLIONS)
      • FIGURE 11: GLOBAL REVENUES FOR COMPANION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)
  • PRODUCTION ANIMALS
    • VIRUSES AND PRIONS
      • Avian Pneumovirus
      • Bovine Spongiform Encephalopathy
      • Bovine Viral Diarrhea
      • Classical Swine Fever
      • Foot and Mouth Disease
      • Furunculosis
      • Infectious Pancreatic Necrosis
      • Marek's Disease
      • Pathogenic Avian Influenza
      • Q Fever
      • Vesicular Stomatitis
    • VACCINE PROVIDERS
      • Bayer
        • TABLE 30: BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
      • Boehringer Ingelheim
        • TABLE 31: BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 12: BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016
      • Elanco
        • TABLE 32: ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 13: ELANCO'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Merck & Co.
        • TABLE 33: MERCK & CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 14: MERCK'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Merial
        • TABLE 34: MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 15: MERIAL'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Zoetis
        • TABLE 35: ZOETIS' PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
        • FIGURE 16: ZOETIS' PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • PRODUCTION ANIMAL VACCINE MARKET ANALYSIS
      • FIGURE 17: GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021
      • FIGURE 18: GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)

CHAPTER 6 - ANIMAL PHARMACEUTICAL PRODUCTS

  • OVERVIEW
  • GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
    • TABLE 36: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 19: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2016-2021 ($ MILLIONS)
  • COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
    • TABLE 37: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • FIGURE 20: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, 2016 (%)
  • MARKETS BY GEOGRAPHICAL REGION
    • TABLE 38: GLOBAL MARKET FOR ANIMAL PHARMACEUTICALS BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 21: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICALS BY REGION, 2016 (%)
  • COMPETITIVE SUMMARY
    • TABLE 39: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS, 2016 ($ MILLIONS)
    • FIGURE 22: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
  • PRODUCT INTRODUCTIONS
    • ALLERGY AND RESPIRATORY DRUGS
      • Companion Animals: Allergy and Inflammatory Diseases
        • Allergies
        • Arthritis
        • Asthma
        • Dermatitis
        • Eosinophilic Granuloma Complex
        • Gout
      • Target Species and Providers
        • Boehringer Ingelheim
          • TABLE 40: BOEHRINGER INGELHEIM'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
        • Elanco
          • TABLE 41: ELANCO'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
        • Heska
          • TABLE 42: HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
        • Huvepharma
          • TABLE 43: HUVEPHARMA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
        • Virbac
          • TABLE 44: VIRBAC'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
        • Zoetis
          • TABLE 45: ZOETIS' ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
          • FIGURE 23: ZOETIS' ALLERGY AND RESPIRATORY DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Allergy and Respiratory Market Analysis
          • FIGURE 24: GLOBAL MARKET FOR ALLERGY AND RESPIRATORY PRODUCTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • ANTI-INFECTIVES AND ANTIFUNGALS
      • Companion Animals - Bacterial Infections
        • Black Tongue
        • Bordetella
        • Brucellosis
        • Campylobacteriosis
        • Chlamydia
        • Leptospirosis
        • Lyme Disease
        • Q Fever
        • Respiratory Mycoplasmosis
        • Spirochaetaceae
        • Tetanus
      • Production Animals - Bacterial Infections
        • Anthrax
        • Blackleg
        • Conjunctivitis
        • Tetanus
        • Ehrlichia Ruminantium (previously known as Heartwater)
        • Pneumonia
      • Providers
        • Bayer
          • TABLE 46: BAYER'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
          • FIGURE 25: BAYER'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Boehringer Ingelheim
          • TABLE 47: BOEHRINGER INGELHEIM'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
        • ECO
          • TABLE 48: ECO ANIMAL HEALTH'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
        • Elanco
          • TABLE 49: ELANCO'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
          • FIGURE 26: ELANCO'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Esteve
          • TABLE 50: ESTEVE'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
        • Merck Animal Health
          • TABLE 51: MERCK'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
          • FIGURE 27: MERCK'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Merial - Sanofi
          • TABLE 52: MERIAL'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
        • Virbac
          • TABLE 53: VIRBAC'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
        • Zoetis
          • TABLE 54: ZOETIS' ANTI-INFECTIVE DRUGS BY TARGET SPECIES
          • FIGURE 28: ZOETIS' ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Anti-Infectives Market Analysis
          • FIGURE 29: GLOBAL MARKET FOR ANTI-INFECTIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • ANTI-INFLAMMATORIES AND ANALGESICS
      • Providers
        • Aratana Therapeutics
          • TABLE 55: ARATANA THERAPEUTICS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Bayer
          • TABLE 56: BAYER ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 57: BOEHRINGER INGELHEIM'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Elanco
          • TABLE 58: ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
          • FIGURE 30: ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Esteve
          • TABLE 59: ESTEVE'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Merck Animal Health
          • TABLE 60: MERCK'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Merial
          • TABLE 61: MERIAL'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
        • Zoetis
          • TABLE 62: ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
          • FIGURE 31: ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Anti-Inflammatory Market Analysis
          • FIGURE 32: GLOBAL MARKET FOR ANTI-INFLAMMATORIES AND ANALGESICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • METABOLIC AND ENDOCRINE DISORDER DRUGS
      • Metabolic Diseases and Endocrine Disorders
        • Cushing's Syndrome
        • Diabetes Mellitus
        • Thyroid Disease
        • Pancreatitis
        • Metabolic Bone Disease in Birds
      • Providers
        • Aratana Therapeutics
          • TABLE 63: ARATANA THERAPEUTICS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
        • Bayer
          • TABLE 64: BAYER'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 65: BOEHRINGER INGELHEIM'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
        • Merck
          • TABLE 66: MERCK'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
          • FIGURE 33: MERCK'S METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
        • Merial
          • TABLE 67: MERIAL'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
        • Virbac
          • TABLE 68: VIRBAC'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
        • Zoetis
          • TABLE 69: ZOETIS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
          • FIGURE 34: ZOETIS' METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Metabolic Drug Market Analysis
          • FIGURE 35: GLOBAL MARKET FOR METABOLIC DRUGS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • PARASITICIDES
      • Companion Animals - Parasitic Diseases
        • Ear Mites
        • Fleas
        • Heartworm
        • Hemotropic Mycoplasmas (formerly Hemobartonellosis)
        • Feline Scabies
        • Lice
        • Sarcoptic Mange
        • Worms
      • Production Animals - Parasitic Disease Example
        • Texas Cattle Fever
      • Providers
        • Bayer
          • TABLE 70: BAYER'S PARASITICIDES BY TARGET SPECIES
          • FIGURE 36: BAYER'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Beaphar
          • TABLE 71: BEAPHAR'S PARASITICIDES BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 72: BOEHRINGER INGELHEIM'S PARASITICIDES BY TARGET SPECIES
        • ECO
          • TABLE 73: ECO ANIMAL HEALTH'S PARASITICIDES BY TARGET SPECIES
        • Elanco
          • TABLE 74: ELANCO'S PARASITICIDES BY TARGET SPECIES
          • FIGURE 37: ELANCO'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Huvepharma
          • TABLE 75: PARASITICIDES BY TARGET SPECIES
        • Merck Animal Health
          • TABLE 76: MERCK'S PARASITICIDES BY TARGET SPECIES
          • FIGURE 38: MERCK'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Merial
          • TABLE 77: MERIAL'S PARASITICIDES BY TARGET SPECIES
          • FIGURE 39: MERIAL'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Virbac
          • TABLE 78: VIRBAC'S PARASITICIDES BY TARGET SPECIES
        • Zoetis
          • TABLE 79: ZOETIS' PARASITICIDES BY TARGET SPECIES
          • FIGURE 40: ZOETIS' PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Parasiticide Market Analysis
        • FIGURE 41: GLOBAL MARKET FOR PARASITICIDES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • PSYCHOTROPIC MEDICATIONS
      • Providers
        • Elanco
          • TABLE 80: ELANCO'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
        • Vetoquinol
          • TABLE 81: VETOQUINOL'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
        • Zoetis
          • TABLE 82: ZOETIS' PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
      • Natural Remedies
      • Psychotropic Market Analysis
        • FIGURE 42: GLOBAL MARKET FOR PSYCHOTROPICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • OTHER PHARMACEUTICALS
      • Companion Animals - Other Diseases
        • Equine Protozoal Myelitis
        • Leptospirosis and Equine Recurrent Uveitis
        • Urinary Diseases
        • Glomerulonephritis
        • Feline Lower Urinary Tract Disease
        • Neoplastic Disease
        • Heart Disease
        • Inflammatory Bowel Disease
      • Providers
        • Bayer
          • TABLE 83: BAYER'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 84: BOEHRINGER INGELHEIM'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Elanco
          • TABLE 85: ELANCO'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Esteve
          • TABLE 86: ESTEVE'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • HbO2 Therapeutics LLC
          • TABLE 87: HBO2 THERAPEUTICS' OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Merck Animal Health
          • TABLE 88: MERCK'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Merial
          • TABLE 89: MERIAL'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Virbac
          • TABLE 90: VIRBAC'S OTHER PHARMACEUTICALS BY TARGET SPECIES
        • Zoetis
          • TABLE 91: ZOETIS' OTHER PHARMACEUTICALS BY TARGET SPECIES
          • FIGURE 43: ZOETIS' OTHER PHARMACEUTICALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Dental
          • TABLE 92: DENTAL PHARMACEUTICALS BY TARGET SPECIES AND PROVIDER
      • Other Pharmaceuticals Market Analysis
        • FIGURE 44: GLOBAL MARKET FOR OTHER PHARMACEUTICALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)

CHAPTER 7 - ANIMAL FEED ADDITIVES

  • OVERVIEW
  • GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
    • TABLE 93: GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 45: GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2014-2021 ($ MILLIONS)
  • COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
    • TABLE 94: GLOBAL MARKET FOR FEED ADDITIVES BY ANIMAL GROUP, THROUGH 2021
    • FIGURE 46: GLOBAL MARKET SHARES OF FEED ADDITIVES BY ANIMAL GROUP, 2016 (%)
  • MARKETS BY GEOGRAPHICAL REGION
    • TABLE 95: GLOBAL MARKET FOR ANIMAL FEED ADDITIVES BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 47: GLOBAL MARKET SHARES OF ANIMAL FEED ADDITIVES BY REGION, 2016 (%)
  • COMPETITIVE SUMMARY
    • TABLE 96: GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 ($ MILLIONS/%)
    • FIGURE 48: GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 (%)
  • PRODUCT INTRODUCTIONS
    • AMINO ACIDS
      • Providers
        • Adisseo - Bluestar
          • TABLE 97: ADISSEO'S AMINO ACIDS BY TARGET SPECIES
        • Ajinomoto
          • TABLE 98: AJINOMOTO'S AMINO ACIDS BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 99: BOEHRINGER INGELHEIM'S AMINO ACIDS BY TARGET SPECIES
        • Evonik
          • TABLE 100: EVONIK'S AMINO ACIDS BY TARGET SPECIES
        • Novus International
          • TABLE 101: NOVUS INTERNATIONAL'S AMINO ACIDS BY TARGET SPECIES
      • Amino Acid Market Analysis
        • FIGURE 49: GLOBAL MARKET FOR AMINO ACIDS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
  • MEDICINAL ADDITIVES
    • Providers
      • ECO
        • TABLE 102: MEDICINAL ADDITIVES BY TARGET SPECIES
      • Elanco
        • TABLE 103: ELANCO'S MEDICINAL ADDITIVES BY TARGET SPECIES
        • FIGURE 50: ELANCO'S MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Huvepharma
      • Merck
        • TABLE 104: MERCK'S MEDICINAL ADDITIVES BY TARGET SPECIES
      • Merial
        • TABLE 105: MERIAL'S MEDICINAL ADDITIVES BY TARGET SPECIES
      • Phibro Animal Health
        • TABLE 106: PHIBRO'S MEDICINAL ADDITIVES BY TARGET SPECIES
      • Zoetis
        • TABLE 107: ZOETIS' MEDICINAL ADDITIVES BY TARGET SPECIES
        • FIGURE 51: ZOETIS' MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Medicinal Feed Additive Market Analysis
        • FIGURE 52: GLOBAL MARKET FOR MEDICINAL FEED ADDITIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • NUTRITIONAL SUPPLEMENTS
      • Providers
        • Adisseo - Bluestar
          • TABLE 108: ADISSEO (BLUESTAR) NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Bayer
          • TABLE 109: BAYER'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • BASF
          • TABLE 110: BASF'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Beaphar
          • TABLE 111: BEAPHAR'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Boehringer Ingelheim
          • TABLE 112: BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
          • FIGURE 53: BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
        • DSM Nutritional Products
          • TABLE 113: DSM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Elanco
          • TABLE 114: ELANCO'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
          • FIGURE 54: ELANCO'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
        • Esteve
          • TABLE 115: ESTEVE'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Heska
          • TABLE 116: HESKA'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Mosaic
          • TABLE 117: MOSAIC'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
        • Virbac
          • TABLE 118: NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
      • Nutritional Supplement Market Analysis
        • FIGURE 55: GLOBAL MARKET FOR NUTRITIONAL SUPPLEMENTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • VITAMINS AND MINERALS
      • Providers
        • Adisseo - Bluestar
          • TABLE 119: ADISSEO'S VITAMINS AND MINERALS BY TARGET SPECIES
        • BASF
          • TABLE 120: BASF'S VITAMINS AND MINERALS BY TARGET SPECIES
        • Beaphar
          • TABLE 121: BEAPHAR'S VITAMINS AND MINERALS BY TARGET SPECIES
        • DSM Nutritional Products
          • TABLE 122: DSM'S VITAMINS AND MINERALS BY TARGET SPECIES
        • Merck Animal Health
          • TABLE 123: MERCK'S VITAMINS AND MINERALS BY TARGET SPECIES
        • Zoetis
          • TABLE 124: ZOETIS' VITAMINS AND MINERALS BY TARGET SPECIES
          • FIGURE 56: ZOETIS' VITAMINS AND MINERALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • Vitamin and Mineral Market Analysis
        • FIGURE 57: GLOBAL MARKET FOR VITAMINS AND MINERALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)

CHAPTER 8 - ANIMAL DIAGNOSTICS

  • OVERVIEW
  • GLOBAL MARKET ANALYSIS AND CONCLUSION
    • TABLE 125: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • FIGURE 58: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, 2014-2021 ($ MILLIONS)
  • COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
    • TABLE 126: GLOBAL MARKET FOR ANIMAL DIAGNOSTIC PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • FIGURE 59: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
  • MARKETS BY GEOGRAPHICAL REGION
    • TABLE 127: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 60: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY REGION, 2016 (%)
    • FIGURE 61: GLOBAL MARKET SHARE OF ANIMAL DIAGNOSTICS BY COUNTRY, 2016 (%)
  • COMPETITIVE SUMMARY
    • TABLE 128: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
    • FIGURE 62: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTIC SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
  • PRODUCT PROVIDERS AND DESCRIPTIONS
    • ABAXIS
      • TABLE 129: ABAXIS' DIAGNOSTICS BY TARGET SPECIES
    • BEAPHAR
      • TABLE 130: BEAPHAR'S DIAGNOSTICS BY TARGET SPECIES
    • HESKA
      • TABLE 131: HESKA'S DIAGNOSTICS BY TARGET SPECIES
      • FIGURE 63: HESKA'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • IDEXX
      • TABLE 132: IDEXX'S DIAGNOSTICS BY TARGET SPECIES
      • FIGURE 64: IDEXX'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • MERCK ANIMAL HEALTH
      • TABLE 133: MERCK'S DIAGNOSTICS BY TARGET SPECIES
    • VIRBAC
      • TABLE 134: VIRBAC'S DIAGNOSTICS BY TARGET SPECIES
      • FIGURE 65: VIRBAC'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • ZOETIS
      • TABLE 135: ZOETIS' DIAGNOSTICS BY TARGET SPECIES
      • FIGURE 66: ZOETIS' DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
      • FIGURE 67: ZOETIS' FELINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
      • FIGURE 68: ZOETIS' CANINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
      • FIGURE 69: ZOETIS' EQUINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
      • FIGURE 70: ZOETIS' RUMINANT DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
      • FIGURE 71: ZOETIS' SWINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
      • FIGURE 72: ZOETIS' AVIAN DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
  • PRODUCT SEGMENTS
    • DIAGNOSTIC RAPID TESTING MARKET ANALYSIS
      • FIGURE 73: GLOBAL MARKET FOR RAPID DIAGNOSTIC TESTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
      • FIGURE 74: GLOBAL MARKET FOR RAPID DIAGNOSTICS BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
    • MARKET ANALYSIS OF DIAGNOSTIC ANALYZERS AND CONSUMABLES
      • FIGURE 75: GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
      • FIGURE 76: GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
    • MARKET ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT
      • FIGURE 77: GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT AND RELATED MATERIALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)

CHAPTER 9 - MARKET SUMMARY

  • GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANALYSIS
    • TABLE 136: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
    • FIGURE 78: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
  • MARKETS BY USE OR ANIMAL GROUP
    • TABLE 137: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP THROUGH 2021 ($ MILLIONS)
    • FIGURE 79: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 80: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
  • MARKETS BY WORLD REGION
    • TABLE 138: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 81: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2014-2021 ($ MILLIONS)
    • FIGURE 82: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2016 (%)
    • FIGURE 83: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SELECT COUNTRY, 2016 (%)
  • COMPETITIVE ANALYSIS
    • TABLE 139: GLOBAL MARKET SHARES AND REVENUE OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER, 2016 ($ MILLIONS/%)
    • FIGURE 84: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2016 (%)
    • TABLE 140: MAJOR INDUSTRY PARTICIPATION BY ANIMAL HEALTH SUPPLIERS

CHAPTER 10 - PATENT ANALYSIS

  • OVERVIEW
  • INNOVATION IN DRUG DELIVERY
    • TRANSDERMAL (SPRAY-ON) DRUGS
    • SUBLINGUAL (UNDER THE TONGUE) DRUGS
    • EFFERVESCENT TABLET VACCINE DELIVERY
    • STERILIZATION METHODS
  • PATENT PRODUCT SEGMENTS
    • PATENTS FILED BY YEAR
      • TABLE 141: ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NUMBER)
      • FIGURE 85: ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NO. OF PATENTS)
    • INTERNATIONAL PATENTS BY COUNTRY
      • TABLE 42: HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • PATENTS ISSUED BY PATENT HOLDER
      • TABLE 143: DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER, JAN. 1, 1976-OCT. 1, 2016 (NUMBER OF PATENTS)

CHAPTER 11 - COMPANY PROFILES

  • OVERVIEW
    • TABLE 144: COMPETITOR MARKET POSITION IN ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SEGMENT, 2016 ($ MILLIONS)
  • PROFILES
    • ABAXIS INC.
    • AJINOMOTO CO. INC.
    • ARATANA THERAPEUTICS INC.
    • BASF ANIMAL NUTRITION
    • BAYER ANIMAL HEALTH GMBH
    • BLUESTAR GROUP-CHINA NATIONAL BLUESTAR CO. LTD.
    • BOEHRINGER INGELHEIM VETMEDICA INC.
    • DSM NUTRITIONAL PRODUCTS LTD.
    • ELANCO ANIMAL HEALTH
    • EVONIK INDUSTRIES AG
    • HESKA CORP.
    • IDEXX LABORATORIES INC.
    • MERCK ANIMAL HEALTH
    • MERIAL SAS
    • MOSAIC CO. (THE)
    • VIRBAC S.A.
    • ZOETIS INC.

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: GESTATION PERIODS OF SELECT COMMON SPECIES
    • TABLE 2: LIFESPAN OF COMMON AVIAN SPECIES OF PETS
    • TABLE 3: STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016 (THOUSANDS/%)
    • TABLE 4: ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016 (THOUSANDS)
    • TABLE 5: REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017 (THOUSANDS)
    • TABLE 6: TOP BROILER PRODUCING STATES, 2015 (THOUSANDS)
    • TABLE 7: TOP RED MEAT PRODUCING STATES, 1990 AND 2015 (%)
    • TABLE 8: DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
    • TABLE 9: CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
    • TABLE 10: HORSE (EQUINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
    • TABLE 11: CATTLE (BOVINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
    • TABLE 12: PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
    • TABLE 13: COMMON EXAMPLES OF ZOONOTIC DISEASES
    • TABLE 14: AFFECTED PIONEER ANTIMICROBIALS USED IN FOOD-PRODUCING ANIMALS IN THE UNITED STATES
    • TABLE 15: ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014 (KG*)
    • TABLE 16: APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS (U.S. SPENDING, $)
    • TABLE 17: PET INSURANCE PLAN COMPARISONS, UNITED STATES
    • TABLE 18: NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015
    • TABLE 19: ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015
    • TABLE 20: GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • TABLE 21: GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
    • TABLE 24: HENDRA VIRUS EQUINE INCIDENTS (NUMBER OF REPORTED CASES)
    • TABLE 25: BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 26: ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 27: MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 28: MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 29: ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 30: BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 31: BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 32: ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 33: MERCK & CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 34: MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 35: ZOETIS' PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
    • TABLE 36: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR ANIMAL PHARMACEUTICALS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS, 2016 ($ MILLIONS)
    • TABLE 40: BOEHRINGER INGELHEIM'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 41: ELANCO'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 42: HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 43: HUVEPHARMA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 44: VIRBAC'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 45: ZOETIS' ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 46: BAYER'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 47: BOEHRINGER INGELHEIM'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 48: ECO ANIMAL HEALTH'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 49: ELANCO'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 50: ESTEVE'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 51: MERCK'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 52: MERIAL'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 53: VIRBAC'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 54: ZOETIS' ANTI-INFECTIVE DRUGS BY TARGET SPECIES
    • TABLE 55: ARATANA THERAPEUTICS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 56: BAYER ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 57: BOEHRINGER INGELHEIM'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 58: ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 59: ESTEVE'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 60: MERCK'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 61: MERIAL'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 62: ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
    • TABLE 63: ARATANA THERAPEUTICS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 64: BAYER'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 65: BOEHRINGER INGELHEIM'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 66: MERCK'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 67: MERIAL'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 68: VIRBAC'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 69: ZOETIS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
    • TABLE 70: BAYER'S PARASITICIDES BY TARGET SPECIES
    • TABLE 71: BEAPHAR'S PARASITICIDES BY TARGET SPECIES
    • TABLE 72: BOEHRINGER INGELHEIM'S PARASITICIDES BY TARGET SPECIES
    • TABLE 73: ECO ANIMAL HEALTH'S PARASITICIDES BY TARGET SPECIES
    • TABLE 74: ELANCO'S PARASITICIDES BY TARGET SPECIES
    • TABLE 75: PARASITICIDES BY TARGET SPECIES
    • TABLE 76: MERCK'S PARASITICIDES BY TARGET SPECIES
    • TABLE 77: MERIAL'S PARASITICIDES BY TARGET SPECIES
    • TABLE 78: VIRBAC'S PARASITICIDES BY TARGET SPECIES
    • TABLE 79: ZOETIS' PARASITICIDES BY TARGET SPECIES
    • TABLE 80: ELANCO'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
    • TABLE 81: VETOQUINOL'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
    • TABLE 82: ZOETIS' PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
    • TABLE 83: BAYER'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 84: BOEHRINGER INGELHEIM'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 85: ELANCO'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 86: ESTEVE'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 87: HBO2 THERAPEUTICS' OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 88: MERCK'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 89: MERIAL'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 90: VIRBAC'S OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 91: ZOETIS' OTHER PHARMACEUTICALS BY TARGET SPECIES
    • TABLE 92: DENTAL PHARMACEUTICALS BY TARGET SPECIES AND PROVIDER
    • TABLE 93: GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 94: GLOBAL MARKET FOR FEED ADDITIVES BY ANIMAL GROUP, THROUGH 2021
    • TABLE 95: GLOBAL MARKET FOR ANIMAL FEED ADDITIVES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 96: GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 ($ MILLIONS/%)
    • TABLE 97: ADISSEO'S AMINO ACIDS BY TARGET SPECIES
    • TABLE 98: AJINOMOTO'S AMINO ACIDS BY TARGET SPECIES
    • TABLE 99: BOEHRINGER INGELHEIM'S AMINO ACIDS BY TARGET SPECIES
    • TABLE 100: EVONIK'S AMINO ACIDS BY TARGET SPECIES
    • TABLE 101: NOVUS INTERNATIONAL'S AMINO ACIDS BY TARGET SPECIES
    • TABLE 102: MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 103: ELANCO'S MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 104: MERCK'S MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 105: MERIAL'S MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 106: PHIBRO'S MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 107: ZOETIS' MEDICINAL ADDITIVES BY TARGET SPECIES
    • TABLE 108: ADISSEO (BLUESTAR) NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 109: BAYER'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 110: BASF'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 111: BEAPHAR'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 112: BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 113: DSM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 114: ELANCO'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 115: ESTEVE'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 116: HESKA'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 117: MOSAIC'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 118: NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
    • TABLE 119: ADISSEO'S VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 120: BASF'S VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 121: BEAPHAR'S VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 122: DSM'S VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 123: MERCK'S VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 124: ZOETIS' VITAMINS AND MINERALS BY TARGET SPECIES
    • TABLE 125: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 126: GLOBAL MARKET FOR ANIMAL DIAGNOSTIC PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
    • TABLE 127: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 128: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
    • TABLE 129: ABAXIS' DIAGNOSTICS BY TARGET SPECIES
    • TABLE 130: BEAPHAR'S DIAGNOSTICS BY TARGET SPECIES
    • TABLE 131: HESKA'S DIAGNOSTICS BY TARGET SPECIES
    • TABLE 132: IDEXX'S DIAGNOSTICS BY TARGET SPECIES
    • TABLE 133: MERCK'S DIAGNOSTICS BY TARGET SPECIES
    • TABLE 134: VIRBAC'S DIAGNOSTICS BY TARGET SPECIES
    • TABLE 135: ZOETIS' DIAGNOSTICS BY TARGET SPECIES
    • TABLE 136: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 137: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP THROUGH 2021 ($ MILLIONS)
    • TABLE 138: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 139: GLOBAL MARKET SHARES AND REVENUE OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER, 2016 ($ MILLIONS/%)
    • TABLE 140: MAJOR INDUSTRY PARTICIPATION BY ANIMAL HEALTH SUPPLIERS
    • TABLE 141: ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NUMBER)
    • TABLE 42 : ESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
    • TABLE 143: DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER, JAN. 1, 1976-OCT. 1, 2016 (NUMBER OF PATENTS)
    • TABLE 144: COMPETITOR MARKET POSITION IN ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SEGMENT, 2016 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
    • FIGURE 1: NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS 2015
    • FIGURE 2: ESTIMATED NUMBER OF VETERINARIANS IN THE UNITED STATES BY GENDER* AND YEAR, 2009-2015
    • FIGURE 3: GLOBAL MARKET SHARES OF ANIMAL VACCINES BY ANIMAL GROUP, 2016 (%)
    • FIGURE 4: GLOBAL MARKET SHARES OF ANIMAL VACCINES BY REGION, 2016 (%)
    • FIGURE 5: GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
    • FIGURE 6: BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 7: MERCK'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 8: MERIAL'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 9: ZOETIS' COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 10: GLOBAL MARKET FOR COMPANION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021 ($ MILLIONS)
    • FIGURE 11: GLOBAL REVENUES FOR COMPANION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 12: BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016
    • FIGURE 13: ELANCO'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 14: MERCK'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 15: MERIAL'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 16: ZOETIS' PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 17: GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021
    • FIGURE 18: GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 19: GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2016-2021 ($ MILLIONS)
    • FIGURE 20: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, 2016 (%)
    • FIGURE 21: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICALS BY REGION, 2016 (%)
    • FIGURE 22: GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
    • FIGURE 23: ZOETIS' ALLERGY AND RESPIRATORY DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 24: GLOBAL MARKET FOR ALLERGY AND RESPIRATORY PRODUCTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 25: BAYER'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 26: ELANCO'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 27: MERCK'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 28: ZOETIS' ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 29: GLOBAL MARKET FOR ANTI-INFECTIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 30: ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 31: ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 32: GLOBAL MARKET FOR ANTI-INFLAMMATORIES AND ANALGESICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 33: MERCK'S METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • FIGURE 34: ZOETIS' METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 35: GLOBAL MARKET FOR METABOLIC DRUGS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 36: BAYER'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 37: ELANCO'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 38: MERCK'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 39: MERIAL'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 40: ZOETIS' PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 41: GLOBAL MARKET FOR PARASITICIDES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 42: GLOBAL MARKET FOR PSYCHOTROPICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 43: ZOETIS' OTHER PHARMACEUTICALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 44: GLOBAL MARKET FOR OTHER PHARMACEUTICALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 45: GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 46: GLOBAL MARKET SHARES OF FEED ADDITIVES BY ANIMAL GROUP, 2016 (%)
    • FIGURE 47: GLOBAL MARKET SHARES OF ANIMAL FEED ADDITIVES BY REGION, 2016 (%)
    • FIGURE 48: GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 (%)
    • FIGURE 49: GLOBAL MARKET FOR AMINO ACIDS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 50: ELANCO'S MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 51: ZOETIS' MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 52: GLOBAL MARKET FOR MEDICINAL FEED ADDITIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 53: BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • FIGURE 54: ELANCO'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 55: GLOBAL MARKET FOR NUTRITIONAL SUPPLEMENTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 56: ZOETIS' VITAMINS AND MINERALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 57: GLOBAL MARKET FOR VITAMINS AND MINERALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 58: GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, 2014-2021 ($ MILLIONS)
    • FIGURE 59: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
    • FIGURE 60: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY REGION, 2016 (%)
    • FIGURE 61: GLOBAL MARKET SHARE OF ANIMAL DIAGNOSTICS BY COUNTRY, 2016 (%)
    • FIGURE 62: GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTIC SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
    • FIGURE 63: HESKA'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • FIGURE 64: IDEXX'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
    • FIGURE 65: VIRBAC'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 66: ZOETIS' DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
    • FIGURE 67: ZOETIS' FELINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 68: ZOETIS' CANINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 69: ZOETIS' EQUINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 70: ZOETIS' RUMINANT DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 71: ZOETIS' SWINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 72: ZOETIS' AVIAN DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
    • FIGURE 73: GLOBAL MARKET FOR RAPID DIAGNOSTIC TESTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 74: GLOBAL MARKET FOR RAPID DIAGNOSTICS BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
    • FIGURE 75: GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 76: GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
    • FIGURE 77: GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT AND RELATED MATERIALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 78: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
    • FIGURE 79: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
    • FIGURE 80: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
    • FIGURE 81: GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2014-2021 ($ MILLIONS)
    • FIGURE 82: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2016 (%)
    • FIGURE 83: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SELECT COUNTRY, 2016 (%)
    • FIGURE 84: GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2016 (%)
    • FIGURE 85: ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH PRODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NO. OF PATENTS)
Back to Top